INS and metabolic dysfunction-associated steatotic liver disease: Zelber-Sagi et al. [50]demonstrated that among different metabolic features, insulin was the strongest predictor of increased serum ferritin levels and that the association between serum ferritin and MS was mediated by NAFLD.